Ethanamine, 2,2,2-trifluoro- → HCID 25113659, compound
Reaction equation
N=C=N.[F:4][C:5]([F:43])([F:42])[C:6]1[CH:7]=[C:8]([C:16]2([C:38]([F:41])([F:40])[F:39])[O:20][N:19]=[C:18]([C:21]3[C:30]4[C:25](=[CH:26][CH:27]=[CH:28][CH:29]=4)[C:24]([C:31]([NH:33][CH2:34][C:35]([OH:37])=O)=[O:32])=[CH:23][CH:22]=3)[CH2:17]2)[CH:9]=[C:10]([C:12]([F:15])([F:14])[F:13])[CH:11]=1.[F:44][C:45]([F:49])([F:48])[CH2:46][NH2:47]>ClCCl>[F:4][C:5]([F:42])([F:43])[C:6]1[CH:7]=[C:8]([C:16]2([C:38]([F:40])([F:41])[F:39])[O:20][N:19]=[C:18]([C:21]3[C:30]4[C:25](=[CH:26][CH:27]=[CH:28][CH:29]=4)[C:24]([C:31]([NH:33][CH2:34][C:35](=[O:37])[NH:47][CH2:46][C:45]([F:49])([F:48])[F:44])=[O:32])=[CH:23][CH:22]=3)[CH2:17]2)[CH:9]=[C:10]([C:12]([F:15])([F:14])[F:13])[CH:11]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
PS-Carbodiimide (400 mg, 123 mmol/g, Argonaut Technologies, Inc.) was added to a stirred mixture of N-[[4-[5-[3,5-bis(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine (i.e. the product of Step C, 140 mg) and 2,2,2-trifluoroethylamine (0.038 mL) in dichloromethane (3 mL) at room temperature. The mixture was stirred at room temperature overnight, then filtered and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel eluted with ethyl acetate/hexanes to provide the title compound (115 mg), a compound of this invention, as a white solid. 1H NMR (CDCl3): δ 8.77 (d, 1H), 8.16 (d, 1H), 8.13 (s, 2H), 8.01 (s, 1H), 7.51-7.60 (m, 3H), 7.46 (t, 1H), 7.42 (d, 1H), 7.33 (d, 1H), 4.31 (d, 1H), 4.23 (d, 2H), 3.83-3.92 (m, 3H).
Workup
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe residue was purified by column chromatography on silica gel
- washeluted with ethyl acetate/hexanes
Sources & evidence
- ORD record
- ord-58ba82bfc2014327871c051a2db1d985
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08410153B2
Reaction notes
Loading…